Does smoking cessation improve quality of life in patients with coronary heart disease?

被引:26
作者
Quist-Paulsen, P
Bakke, PS
Gallefoss, F
机构
[1] Sorlandet Hosp Kristiansand, Dept Internal Med, Kristiansand, Norway
[2] Univ Bergen, Inst Internal Med, Bergen, Norway
关键词
quality of life; smoking cessation; coronary heart disease; myocardial infarction;
D O I
10.1080/14017430500384855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To evaluate whether smoking cessation after a coronary event improves quality of life, and to assess whether quality of life is a predictor of smoking cessation. Design. Health-related quality of life at baseline and at 12 months follow up were measured in a randomised smoking cessation trial of 240 smokers aged under 76 years admitted for myocardial infarction, unstable angina or coronary bypass surgery. At 12 months follow up 101 had managed to give up smoking (quitters), and 117 were smokers (sustained smokers). Results. The quitters and sustained smokers had similar improvements in all quality of life domains from baseline to 12 months follow up. Further, after adjustment for differences in baseline characteristics, the quality of life was not significantly different in the quitters compared to the sustained smokers neither at baseline nor at 12 months follow up. Conclusions. Smoking cessation did not improve quality of life compared to sustained smoking after a coronary event in a 12 month follow up. Quality of life was not a significant predictor of smoking cessation.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 23 条
[1]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[2]   LISINOPRIL VERSUS PLACEBO IN THE TREATMENT OF HEART-FAILURE - THE LISINOPRIL HEART-FAILURE STUDY-GROUP [J].
BELLER, B ;
BULLE, T ;
BOURGE, RC ;
COLFER, H ;
FOWLES, RE ;
GILES, TD ;
GROVER, J ;
WHIPPLE, JP ;
FISHER, MB ;
JESSUP, M ;
NAGGAR, C ;
ALEXANDER, S ;
PARKER, BM ;
SMITH, E ;
WEIDLER, DJ ;
WERTHEIMER, J .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (07) :673-680
[3]   MORICIZINE AND QUALITY-OF-LIFE IN THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL-II (CAST-II) [J].
BROOKS, MM ;
GORKIN, L ;
SCHRON, EB ;
WIKLUND, I ;
CAMPION, J ;
LEDINGHAM, RB .
CONTROLLED CLINICAL TRIALS, 1994, 15 (06) :437-449
[4]   Mortality risk reduction associated with smoking cessation in patients with coronary heart disease - A systematic review [J].
Critchley, JA ;
Capewell, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (01) :86-97
[5]   LONG-TERM EFFECT ON MORTALITY OF STOPPING SMOKING AFTER UNSTABLE ANGINA AND MYOCARDIAL-INFARCTION [J].
DALY, LE ;
MULCAHY, R ;
GRAHAM, IM ;
HICKEY, N .
BMJ-BRITISH MEDICAL JOURNAL, 1983, 287 (6388) :324-326
[6]   Inadequate response to treatment in coronary heart disease - Adverse effects of type D personality and younger age on 5-year prognosis and quality of life [J].
Denollet, J ;
Vaes, J ;
Brutsaert, DL .
CIRCULATION, 2000, 102 (06) :630-635
[7]  
FALLOWFIELD L, 1993, BRIT HEART J, V69, P371
[8]  
FLYNN MK, 1987, HEART LUNG, V16, P159
[9]   MEASUREMENT OF HEALTH-RELATED QUALITY-OF-LIFE IN HEART-FAILURE [J].
GUYATT, GH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) :A185-A191
[10]   Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J].
Hjalmarson, Å ;
Goldstein, S ;
Fagerberg, B ;
Wedel, H ;
Waagstein, F ;
Kjekshus, J ;
Wikstrand, J ;
El Allaf, D ;
Vítovec, J ;
Aldershvile, J ;
Halinen, M ;
Dietz, R ;
Neuhaus, KL ;
Jánosi, A ;
Thorgeirsson, G ;
Dunselman, PHJM ;
Gullestad, L ;
Kuch, J ;
Herlitz, J ;
Rickenbacher, P ;
Ball, S ;
Gottlieb, S ;
Deedwania, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1295-1302